Doctors search past records to find best treatment for deadly fungus
NCT ID NCT07191756
Summary
This study aims to help doctors choose the better medicine for treating mucormycosis, a rare but dangerous fungal infection. Researchers will look back at the medical records of 150 patients who were treated with either amphotericin B or isavuconazole. They will compare which drug helped patients survive longer and caused fewer serious side effects like kidney or liver problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCORMYCOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangxi Medical University
Nanning, Guangxi, China
Conditions
Explore the condition pages connected to this study.